Suzanne Lentzsch, MD, PhD
Dr. Suzanne Lentzsch is a Professor of Clinical Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York. She is at New York Presbyterian Hospital/ Columbia University Medical Center. After receiving her degrees from the Humboldt University/ Charité Berlin, Germany, she completed her residency and fellowship at Humboldt University. She did a research fellowship, studying the mechanism of action of thalidomide and its derivatives in multiple myeloma, in the Jerome Lipper Multiple Myeloma Center under the mentorship of Dr. Kenneth Anderson at the Dana-Farber Cancer Institute, Boston, Massachusetts, United States.
Dr. Lentzsch was recruited in August 2004 to the University of Pittsburgh and University of Pittsburgh Cancer Institute (UPCI), Pennsylvania and served as Clinical Director of the Multiple Myeloma Program at UPCI before accepting the position as Director of the Multiple Myeloma and Amyloidosis Program at Columbia University Medical Center. She cares primarily for patients with plasma cell dyscrasia including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma, amyloidosis, POEMS and Waldenstrom’s macroglobulinemia. Dr. Lentzsch is an internationally recognized expert in the field of multiple myeloma and amyloidosis.
Representative Publications:
Beyond NEOD001 for Systemic Light-chain Amyloidosis
Interim Analysis of the Phase 1a/B Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1f4 in Patients With Al Amyloidosis
Daratumumab Plus Bortezomib and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Updated Analysis of CASTOR
IMiD Compounds Affect CD34+ Cell Fate and Maturation via CRBN-induced IKZF1 Degradation
Targeting Transcription Factors in Multiple Myeloma: Evolving Therapeutic Strategies
